With many brokers still taking a well-earned break over the holiday period, broker notes are few and far between right now.
In light of this, I thought I would take a look at a few that have been released over the last few weeks that remain very relevant today.
Three buy ratings that you might want to pay attention to are listed below:
Bapcor Ltd (ASX: BAP)
According to a note out of Citi, its analysts have retained their buy rating and lifted the price target on this auto parts retailer’s shares to $8.85. The broker made the move in response to the release of a trading update from Bapcor which revealed stronger than expected sales growth in FY 2021. Citi expects this to result in a solid half year result in February. In addition to this, its analysts are fans of the company due to its defensive qualities, favourable tailwinds, and international expansion plans. The Bapcor share price is trading at $7.57 this afternoon.
Challenger Ltd (ASX: CGF)
A note out of UBS reveals that its analysts have reinstated coverage on this annuities company’s shares with a buy rating and price target of $6.85. According to the note, the broker still sees value in the Challenger share price at the current level after it recovered from a selloff at the height of the pandemic. In addition, UBS believes the risks are now to the upside in respect to Challenger’s earnings, especially given favourable regulatory developments. The Challenger share price is trading at $6.36 on Wednesday.
Pro Medicus Limited (ASX: PME)
Analysts at Morgans have retained their add rating and lifted the price target on this health imaging company’s shares to $35.02. According to the note, the broker points out that Pro Medicus has just won another major contract in the United States. The five-year contract with MedStar Health is worth a total of A$18 million. Morgans points out that this is the first time the company has signed a major cloud-only deal. It feels this could be a sign of things to come. The Pro Medicus share price is changing hands for $32.86 today.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
More reading
- How ASX shares in the automotive sector outperformed the market in 2020
- Are heads in the clouds with these sky high P/E ratios?
- Challenger (ASX:CGF) share price is up 35% in 6 months. Can it continue its form in 2021?
- Which ASX 200 healthcare shares delivered the top returns in 2020?
- ASX 200 up 0.8%: CBA storms higher, Link sinks, tech shares rise
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Bapcor, Challenger Limited, and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3pTq8Nr
Leave a Reply